Zhang Wan-Wan, Zhang Ya-Li, Ren Chong-Chong, Wu Ting-Kai, Liu Bei
The First Clinical Medical College of Lanzhou University, The First Hospital of Lanzhou University, Lanzhou 730000, Gansu Province, China.
Department of Hematology, The First Hospital of Lanzhou University, Lanzhou 730000, Gansu Province, China.E-mail:
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Feb;32(1):176-183. doi: 10.19746/j.cnki.issn.1009-2137.2024.01.028.
To explore the correlation between gene mutations and clinical characteristics, prognosis of myelodysplastic syndromes (MDS).
Clinical data of 131 patients with MDS were collected from the First Hospital of Lanzhou University from June 2015 to February 2023, which 19 of them developed into secondary acute myeloid leukemia (sAML) during follow-up time. Second generation sequencing technology was used to detect the mutation types of MDS disease-related genes, drawn gene maps, and analyzed their correlation and prognosis based on the clinical data of patients.
The median age of 131 MDS patients was 58(17-86) years old. The ratio of male to female was 1.3∶1. A total of 148 gene mutations and 25 types were found in the center. and were often co-mutations with other genes, which were accompanied by 20q- and normal karyotype (NK) respectively. and were more common in patients over 60 years old, while and under 60 years. Older patients had a higher the number of genetic mutations than younger patients. The incidence of and in males was higher than females and in females was higher than males. The number of gene mutations in sAML was higher than MDS (1.8 1.0, =0.006). The univariate and multivariate analysis showed that IPSS-R prognostic score≥3.5, were adverse factors for poor prognosis in MDS patients. Patients with monoallelic mutation(ma-)and wild-type(wt-) had OS better than biallelic mutation(bi-)( =0.003). The OS of MDS patients was better than sAML( =0.01) and transplant patients was significantly better than nontransplant patients( =0.036).
Gene mutation is closely related to cytogenetic indexes and clinical features (peripheral blood cell count, sex, age). IPSS-R prognostic score and were risk factors affecting OS in MDS patients.
探讨骨髓增生异常综合征(MDS)基因突变与临床特征、预后的相关性。
收集2015年6月至2023年2月兰州大学第一医院131例MDS患者的临床资料,其中19例在随访期间发展为继发性急性髓系白血病(sAML)。采用二代测序技术检测MDS疾病相关基因的突变类型,绘制基因图谱,并根据患者临床资料分析其相关性及预后。
131例MDS患者中位年龄58(17 - 86)岁,男女比例为1.3∶1。共检测到148个基因突变,25种类型。 和 常与其他基因共突变,分别伴有20q-和正常核型(NK)。 和 在60岁以上患者中更常见,而 和 在60岁以下患者中更常见。老年患者基因突变数量多于年轻患者。 和 在男性中的发生率高于女性,而 在女性中的发生率高于男性。sAML患者基因突变数量高于MDS患者(1.8比1.0,P = 0.006)。单因素和多因素分析显示,国际预后评分系统(IPSS-R)预后评分≥3.5、 是MDS患者预后不良的危险因素。单等位基因突变(ma-)和野生型(wt-) 的患者总生存期(OS)优于双等位基因突变(bi-)(P = 0.003)。MDS患者的OS优于sAML患者(P = 0.01),移植患者的OS明显优于非移植患者(P = 0.036)。
基因突变与细胞遗传学指标及临床特征(外周血细胞计数、性别、年龄)密切相关。IPSS-R预后评分和 是影响MDS患者OS的危险因素。